BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28679323)

  • 1. The apparent diffusion coefficient is strongly correlated with extracellular volume, a measure of myocardial fibrosis, and subclinical cardiomyopathy in patients with systemic lupus erythematosus.
    Wu R; An DA; Hu J; Jiang M; Guo Q; Xu JR; Wu LM
    Acta Radiol; 2018 Mar; 59(3):287-295. PubMed ID: 28679323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
    Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial fibrosis evaluated by diffusion-weighted imaging and its relationship to 3D contractile function in patients with hypertrophic cardiomyopathy.
    Wu R; An DA; Shi RY; Chen BH; Jiang M; Bacyinski A; Han TT; Hu J; Xu JR; Wu LM
    J Magn Reson Imaging; 2018 Oct; 48(4):1139-1146. PubMed ID: 29601139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial fibrosis associates with lupus anticoagulant in patients with systemic lupus erythematosus.
    Myhr KA; Zinglersen AH; Pecini R; Jacobsen S
    Int J Cardiovasc Imaging; 2024 Jan; 40(1):127-137. PubMed ID: 37814154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus.
    Puntmann VO; D'Cruz D; Smith Z; Pastor A; Choong P; Voigt T; Carr-White G; Sangle S; Schaeffter T; Nagel E
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):295-301. PubMed ID: 23403334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.
    Nakamori S; Dohi K; Ishida M; Goto Y; Imanaka-Yoshida K; Omori T; Goto I; Kumagai N; Fujimoto N; Ichikawa Y; Kitagawa K; Yamada N; Sakuma H; Ito M
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):48-59. PubMed ID: 28624408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis.
    Gao Y; Wang HP; Liu MX; Gu H; Yuan XS; Biekan J; Wang XM
    Eur Radiol; 2023 Mar; 33(3):1982-1991. PubMed ID: 36241919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive evaluation of macroscopic and microscopic myocardial fibrosis by cardiac MR: intra-individual comparison of gadobutrol versus gadoterate meglumine.
    Rahsepar AA; Ghasemiesfe A; Suwa K; Dolan RS; Shehata ML; Korell MJ; Naresh NK; Markl M; Collins JD; Carr JC
    Eur Radiol; 2019 Aug; 29(8):4357-4367. PubMed ID: 30617490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.
    Ugander M; Oki AJ; Hsu LY; Kellman P; Greiser A; Aletras AH; Sibley CT; Chen MY; Bandettini WP; Arai AE
    Eur Heart J; 2012 May; 33(10):1268-78. PubMed ID: 22279111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-free detection of myocardial fibrosis in hypertrophic cardiomyopathy patients with diffusion-weighted cardiovascular magnetic resonance.
    Nguyen C; Lu M; Fan Z; Bi X; Kellman P; Zhao S; Li D
    J Cardiovasc Magn Reson; 2015 Dec; 17():107. PubMed ID: 26631061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The feasibility and diagnostic value of intravoxel incoherent motion diffusion-weighted imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy patients.
    Wu R; An DA; Shi RY; Chen BH; Wu CW; Jiang M; Xu JR; Wu LM; Pu J
    Eur J Radiol; 2020 Nov; 132():109333. PubMed ID: 33068839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Detection of Silent Myocardial Impairment in Drug-Naive Patients With New-Onset Systemic Lupus Erythematosus: A Three-Center Prospective Study.
    Guo Q; Wu LM; Wang Z; Shen JY; Su X; Wang CQ; Gong XR; Yan QR; He Q; Zhang W; Xu JR; Jiang M; Pu J
    Arthritis Rheumatol; 2018 Dec; 70(12):2014-2024. PubMed ID: 30070061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy.
    Soslow JH; Damon SM; Crum K; Lawson MA; Slaughter JC; Xu M; Arai AE; Sawyer DB; Parra DA; Damon BM; Markham LW
    J Cardiovasc Magn Reson; 2016 Jan; 18():5. PubMed ID: 26795569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T.
    de Meester de Ravenstein C; Bouzin C; Lazam S; Boulif J; Amzulescu M; Melchior J; Pasquet A; Vancraeynest D; Pouleur AC; Vanoverschelde JL; Gerber BL
    J Cardiovasc Magn Reson; 2015 Jun; 17(1):48. PubMed ID: 26062931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance.
    Barison A; Gargani L; De Marchi D; Aquaro GD; Guiducci S; Picano E; Cerinic MM; Pingitore A
    Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):74-80. PubMed ID: 25190071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects.
    Hong YJ; Park CH; Kim YJ; Hur J; Lee HJ; Hong SR; Suh YJ; Greiser A; Paek MY; Choi BW; Kim TH
    Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():115-22. PubMed ID: 25634119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, distribution and clinical correlates of myocardial fibrosis in systemic lupus erythematosus: a cardiac magnetic resonance study.
    Seneviratne MG; Grieve SM; Figtree GA; Garsia R; Celermajer DS; Adelstein S; Puranik R
    Lupus; 2016 May; 25(6):573-81. PubMed ID: 26700183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Native T1 Mapping, Extracellular Volume Mapping, and Late Gadolinium Enhancement in Cardiac Amyloidosis: A Meta-Analysis.
    Pan JA; Kerwin MJ; Salerno M
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1299-1310. PubMed ID: 32498919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.